TITLE

Cytoreductive Surgery in Patients with Advanced-Stage Carcinoid Tumors

AUTHOR(S)
Gulec, Seza A.; Mountcastle, Timothy S.; Frey, Daniel; Cundiff, Jason D.; Mathews, Elizabeth; Anthony, Lowell; O'Leary,, J. Patrick; Boudreaux, J. Philip
PUB. DATE
August 2002
SOURCE
American Surgeon;Aug2002, Vol. 68 Issue 8, p667
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The role of aggressive surgical resections as well as criteria for resectability in patients with advanced carcinoid tumors is not clearly defined. Thirty patients (17 male and 13 female) who were previously diagnosed to have "unresectable carcinoid disease" were treated using a multimodality approach over a period of 2 years. Extensive liver involvement was present in 28 of 30 (93%) of the cases. Small bowel involvement was noted in 22 of 30 (73%), and peritoneal/retroperitoneal/mesenteric invasion was observed in 15 of 30 (50%) of the cases. Three patients had remote metastases (brain, bone, and eye). Twenty of 30 (66%) patients had carcinoid syndrome with severely disabling symptoms. Eight patients (26%) had small bowel obstruction. All patients underwent at least one surgical exploration/intervention. Radiofrequency ablation (RFA) of one or more liver lesions was performed as an adjunct in 22 of 30 (73%) patients. Six patients (20%) had a second surgical procedure. There were 11 complications in eight patients (27%) after the initial operation. Median hospital stay for patients who underwent RFA only, RFA/liver resection, and liver resection with abdominal tumor debulking were 2,4, 8, and 16 days respectively. Twenty-five of 30 patients (83%) showed symptomatic improvement. Mean pre- and postoperative Karnofsky physical performance scores were 55 and 85 respectively (P < 0.02). Small bowel obstruction was due to adhesions in five patients. All patients with intestinal obstruction had complete relief of their symptoms postoperatively. 5-Hydroxyindolacetic acid levels decreased by 50 per cent in all patients with follow-up determinations available. Aggressive surgical exploration and tumor debulking could be performed with significantly improved symptomatic outcome and relatively minor complications. Longer follow-up is needed for assessment of effect on survival.
ACCESSION #
7743173

 

Related Articles

  • Efficacy of endoscopic mucosal resection using a dual-channel endoscope compared with endoscopic submucosal dissection in the treatment of rectal neuroendocrine tumors. Lee, Wook-Hyun; Kim, Sang-Woo; Lim, Chul-Hyun; Kim, Jin-Soo; Cho, Yu-Kyung; Lee, In-Seok; Choi, Myung-Gyu; Choi, Kyu-Yong // Surgical Endoscopy;Nov2013, Vol. 27 Issue 11, p4313 

    Background: Conventional endoscopic mucosal resection (EMR) for removing rectal neuroendocrine tumors (NETs) has a high risk of incomplete removal because of submucosal tumor involvement. EMR using a dual-channel endoscope (EMR-D) may be a safe and effective method for resection of polyps in the...

  • Squamous Differentiation in High Grade Large Cell Neuroendocrine Carcinoma of Ampulla of Vater. Gulwani, Hanni; Roy, Subimal; Chopra, P. // Internet Journal of Pathology;2008, Vol. 7 Issue 1, p15 

    Neuroendocrine tumors constitute a spectrum of lesions with varied morphology and clinical behavior. High grade neuroendocrine carcinoma includes both small cell and large cell neuroendocrine carcinoma (LCNEC). LCNEC in ampullary region is rare with only few cases reported in literature....

  • Merkel cell carcinoma: Report Of Two Patients. Sodhi, Kuljinder; Chaturvedi, Arun; Misra, Sanjeev; Kumar, Vijay; Athar, Mohd; Srivastava, Manoj; Husain, Nuzhat // Internet Journal of Oncology;2008, Vol. 5 Issue 2, p8 

    Merkel cell carcinoma (MCC) is a rare malignant cutaneous tumor of the elderly that is characterized by an aggressive course with regional nodal involvement, distant metastases and a high rate of recurrence. It is a very rare tumor with an annual incidence of approximately 0.42 per 100,000. We...

  • Squamous Differentiation in High Grade Large Cell Neuroendocrine Carcinoma of Ampulla of Vater. Gulwani, Hanni; Roy, Subimal; Chopra, P. // Internet Journal of Pediatrics & Neonatology;2008, Vol. 7 Issue 1, p15 

    Neuroendocrine tumors constitute a spectrum of lesions with varied morphology and clinical behavior. High grade neuroendocrine carcinoma includes both small cell and large cell neuroendocrine carcinoma (LCNEC). LCNEC in ampullary region is rare with only few cases reported in literature....

  • Staged surgery with neoadjuvant 90Y-DOTATOC therapy for down-sizing synchronous bilobular hepatic metastases from a neuroendocrine pancreatic tumor. Stoeltzing, Oliver; Loss, Martin; Huber, Elisabeth; Gross, Volker; Eilles, Christoph; Mueller-Brand, Jan; Schlitt, Hans J. // Langenbeck's Archives of Surgery;Feb2010, Vol. 395 Issue 2, p185 

    Treatment with DOTA- d-Phe(1)-Tyr(3)-octreotide (DOTATOC), labeled with beta-emitting radioisotope yttrium-90 (90Y-DOTATOC), has successfully been used for the palliative treatment of patients with advanced somatostatin receptor-expressing neuroendocrine tumors (NETs). However, controversy...

  • Clinical Features and Medical Treatment of Male Prolactinomas. Asano, S.; Ueki, K.; Suzuki, I.; Kirino, T. // Acta Neurochirurgica;Jun2001, Vol. 143 Issue 5, p465 

    Summary Background. Prolactinomas found in male patients show distinct clinical features compared to those in female patients, which may warrant a different treatment strategy. Method. To clarify their clinical features and to evaluate the treatment results, specifically the results of surgical...

  • A case of long-term recurrence-free poorly differentiated neuroendocrine carcinoma of lymph nodes treated by surgical resection without any chemotherapy. Hisamori, Shigeo; Okabe, Hiroshi; Yoshizawa, Akihiko; Sakai, Yoshiharu // International Journal of Clinical Oncology;Oct2010, Vol. 15 Issue 5, p493 

    77-year-old man presented with a 2-month history of an enlarged right inguinal lymph node. Diagnostic excisional biopsy of the inguinal lymph node proved it to be a poorly differentiated neuroendocrine carcinoma by histological and immunohistological analyses. We diagnosed a poorly...

  • Low-Grade Esthesioneuroblastoma Presenting as SIADH: A Review of Atypical Manifestations. Senchak, Andrew; Freeman, Judy; Ruhl, Douglas; Senchak, Jordan; Klem, Christopher // Case Reports in Otolaryngology;2012, p1 

    Esthesioneuroblastoma (ENB) is a neuroendocrine tumor that typically manifests as advanced stage malignancy in the superior nasal cavity. The hallmark symptoms include nasal obstruction and epistaxis, which result from local tissue invasion. Atypical clinical features can also arise and must be...

  • Natural History of Surgically Treated Mucosal Melanoma. Steven Padilla, R. // Journal of Dermatologic Surgery & Oncology;Jan88, Vol. 14 Issue 1, p66 

    This article focuses on the paper "Natural History of Surgically Treated Mucosal Melanoma," by J. Wong, L. Cagle, K. Storm and D. Morton, published in a previous issue of "Journal of Dermatologic Surgery and Oncology." This retrospective analysis helps define clearer management guidelines for...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics